Drugs / ALD-601
last change Mar 2017 re-read 3 minutes ago

ALD-601

Cell therapy

Developed for
lysosomal storage disease
Investigated by
Aldagen · Joanne Kurtzberg, MD

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01003912 Oct 2009 → Mar 2017 lysosomal storage disease Joanne Kurtzberg, MD Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ALD-601 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01003912 ↗
Modality Cell therapy “fetal stem cell therapy” NCT01003912 ↗